Bethesda Psychiatry MD – Chevy Chase, Maryland Ketamine Clinics, Spravato Clinics

✓ Last verified: April 15, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Chevy Chase psychiatrist offering Spravato and TMS in the Bethesda corridor.

💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.

HealingMaps Take: Bethesda Psychiatry MD adds a second Spravato option to the Chevy Chase area, giving patients in the Bethesda corridor a choice of providers. Dr. Amita Jha pairs Spravato with TMS — two FDA-approved interventional treatments that can complement each other for patients with treatment-resistant depression. The Bradley Boulevard location is convenient for patients in Bethesda, Chevy Chase, and the surrounding Montgomery County communities. While the treatment menu is narrower than some competitors, the focused Spravato-plus-TMS combination represents a well-curated interventional approach for depression that has not responded to traditional medications.

Market Position: Bethesda Psychiatry MD is a Spravato-certified clinic in the Chase metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.

Bethesda Psychiatry MD Ketamine Cost Calculator

Ketamine Protocols Compared — What’s Offered at Bethesda Psychiatry MD

Industry pricing reference. Bethesda Psychiatry MD has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.

What to Expect at Your First Bethesda Psychiatry MD Appointment

1. Initial intake call — Insurance verification, prior authorization workflow (Spravato requires documentation of failure on at least two antidepressant trials), and clinical eligibility check. Call (202) 999-5712 to schedule.
2. Medical evaluation — in-person or telehealth psychiatric assessment, vitals check, and review of current medications with the Bethesda Psychiatry MD clinical team.
3. First treatment session — supervised Spravato (intranasal esketamine) in a private treatment room, lasting approximately 90 minutes (40-minute session + 60 minutes monitoring). Sessions are held at 4905 Bradley Blvd, Chevy Chase, MD 20815. You’ll have a comfortable chair or recliner, dim lighting, and direct medical monitoring throughout.
4. Recovery and follow-up — observation period after dosing, mood check-in with the clinical team, and scheduling your next session. Arrange for a ride home; do not drive for 24 hours after your Spravato session.

What to Ask on Your Bethesda Psychiatry MD Consult Call

• How long has the Bethesda Psychiatry MD clinical team been delivering ketamine therapy, and what specialty training do your providers hold?
• How long does Bethesda Psychiatry MD’s Spravato prior authorization typically take with my specific insurance plan, and what happens if it’s denied?
• Have you obtained Spravato authorization through CareFirst BCBS, Aetna, or Kaiser Permanente Mid-Atlantic — and what’s the typical timeline?
• What does Bethesda Psychiatry MD recommend for patients who don’t respond to the standard 6-session acute series?

Patient Questions about Bethesda Psychiatry MD

This 2-question summary is matched to the protocols and conditions Bethesda Psychiatry MD treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.

Does Bethesda Psychiatry MD offer Spravato (esketamine)?

Yes — Bethesda Psychiatry MD offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.

Is Bethesda Psychiatry MD suited for treatment-resistant depression?

Bethesda Psychiatry MD treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.

Learn more about the evidence behind ketamine for depression at the National Institute of Mental Health.

View all REMS-certified Spravato clinics in Maryland and across the United States.

Location